Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 70.00 |
---|---|
High | 72.00 |
Low | 70.00 |
Bid | 70.50 |
Offer | 71.00 |
Previous close | 70.00 |
Average volume | 2.85k |
---|---|
Shares outstanding | 178.90m |
Free float | 177.09m |
P/E (TTM) | -- |
Market cap | 13.09bn USD |
EPS (TTM) | -5.56 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 15:10 GMT.
More ▼
Press releases
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Insmed To Present at November 2024 Investor Conferences
- Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update
- Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List
- Insmed Unites Across Communities Around the World During Third Annual Global Day of Good
- Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024
- New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results
More ▼